Jean-Luc Marsat

Jean-Luc Marsat has a long and varied career in the business world. Jean-Luc has held a number of positions in different companies, beginning in 1993 with Essilor, where they served as Managing Director of Essilor Ireland and Marketing Director of Spain and the UK. In 2003, they moved to FDI LOG BOX as General Manager of the UK and Scandinavia, where they were responsible for a €100 million business with 30 staff. In 2004, they joined Arthur D. Little as a Senior Consultant-Associate. Jean-Luc then moved to MDS Pharma Services in 2008 as Director of European Operations, and in 2010 they became General Manager of France and Cardiac Services at Clearstone Central Laboratories. In 2011, they joined SGS as Managing Director of Worldwide Clinical Research, and in 2017 they became a Partner at AEC Partners. Most recently, in 2021, they were appointed Chief Executive Officer and President of EverImmune.

Jean-Luc Marsat earned a Master's degree in Bio engineering from ENSAIA in 1983, with a focus in Food Science and Technology. In 2001, they received an Executive MBA from HEC Paris, with a focus in International Business.